Evidence appraisal
Check product identity, authorised claims, formulation, dose and populations. Deliver sources, applicability and gaps.
Acceptance: traceable claims with clear support and limitations.
EOS MEDICAL EVIDENCE · CATEGORY SERVICE
Health foods & supplements
Vitamins, minerals, fish oils and combination supplements
HEALTH BRANDS & SUPPLEMENTS · COMMERCIAL EVIDENCE DELIVERY
Support purchase decisions with evidence. Measure the sales value.
Clients want sales growth. EOS first appraises the evidence, then applies it to consumer comparisons, agent answers and partner diligence, and evaluates exposure, enquiries, payments and margin while following brand trust, reputation and repeat purchases.
FIRST DELIVERY · GLOBAL AGENT STRATEGY
Identify discovery routes before deciding how to produce and publish evidence.
Official mechanisms reviewed for eight major platforms, separating web retrieval, citations, product display and active tool integrations. EOS supplies trustworthy living evidence within a loop linking client products, channels and outcomes.
ChatGPTGoogle AI SearchBing / CopilotPerplexity百度 AI 搜索豆包 / 火山方舟KimiDeepSeek
Inspect global strategy, publication routes and the commercial loopShow the work alongside the before-and-after change.Inspect the comparison, work log and long-term measures
Before
Archive existing claims, pages and channel performance.
EOS work
Appraise evidence, create buying/partner materials, connect the product and measure.
After
Report exposure/conversion differences and follow trust, referrals and net repeat purchases.
Purchase & partner materials
Turn reviewed evidence into FAQs, selection/comparison pages, product-page modules and partner briefs, mapped to sources and conditions.
Acceptance: accessible evidence and answers to agreed purchase questions.
Commercial validation
Deliver fixed-query agent test logs, a concurrent conversion-pilot protocol and an outcome report covering enquiries, net purchases and incremental margin.
Acceptance: auditable records and definitions, whether results improve or not.
Agent discovery rateDiscovery Rate
Accurate citation rateCitation Accuracy
Qualified enquiry rateQualified Enquiry Rate
Net purchase conversion rateCVR · Conversion Rate
Conversion liftUplift · Incrementality
Incremental contribution marginContribution Margin
Brand-information trust90-day referrals & net repeat purchases180-day realised customer contribution
Evidence determines scientific findings; commercial pilots assess sales effects. Papers, evidence pages and integrations have distinct uses, and their contribution to actual purchasing needs measurement.
EVIDENCE TO PURCHASE · AUDITABLE MEASUREMENT
From agent discovery to paid conversion: how do we validate the work?
Here, “the chance of being found” means discovery in a predefined agent query test. Conversion means net purchases by actual visitors. Measure both to locate value and remaining gaps.
Six core measures with denominators and data sources.
| Measure / term | Definition | Verification data |
|---|---|---|
| Agent discovery rateDiscovery Rate | Answers naming the target product with an accessible evidence link ÷ all completed test answers. | Fixed queries, platform/model, language, date, original answers and links. |
| Accurate citation rateCitation Accuracy | Answers correctly citing the target product’s designated evidence page or registered sources, with accurate relevant findings and limits ÷ all completed test answers. | Original answers, cited sources and review records; a product mention alone does not qualify. |
| Qualified enquiry rateQualified Enquiry Rate | Unique visitors with a qualified enquiry in the agreed window ÷ unique visitors in that same traceable, eligible cohort. | Source tags/dedicated links, site records and CRM; define eligible customers and genuine enquiries in advance. |
| Net purchase conversion rateCVR · Conversion Rate | Unique visitors retaining at least one paid order not fully refunded within the window ÷ all eligible visitors. | Visitor assignment, orders, payments and refunds; partial refunds reduce net revenue. |
| Conversion liftUplift · Incrementality | Evidence-group CVR − concurrent control-group CVR, in percentage points with uncertainty. | Concurrent random A/B assignment and order records; report relative lift separately and treat before/after changes as observational. |
| Incremental contribution marginContribution Margin | Evidence-group net revenue less variable costs, minus the control contribution margin adjusted for visitor count. | Orders, refunds and product/fulfilment/payment/channel-commission variable costs; deduct service and pilot promotion spend once, separately in ROI. |
Discovery and citation rates use project-defined test criteria, not an industry certification. Freeze platform, queries, language, region and date; log repetitions and failures and report completed/failed counts. Results do not estimate discovery across all agents or consumers. Enquiries and payments require actual records; button clicks indicate intent only.
How is the pilot assessed, and who supplies the data?
Define goals and baseline
Freeze one SKU, population and channel. Agree the primary measure, eligible visitors, attribution/refund windows, minimum meaningful effect and sample size before the pilot; targets remain to be agreed.
Fixed-query agent testing
Propose about 50 purchase queries, repeated three times per platform. Separate brand and non-brand queries and retain answers. Record mentions, sources and recommendations separately; repetitions assess stability.
Concurrent sales A/B test
Randomly show current materials or materials enhanced with reviewed evidence in one channel. Keep price/promotions consistent and record availability changes. Use orders/refunds to assess lift and uncertainty; insufficient samples remain inconclusive.
EOS handles appraisal, evidence-to-content mapping, the evaluation protocol and analysis. Clients supply and verify product records, channel permissions, visitors, orders/refunds and variable costs. Report traceable agent traffic separately from unknown origins. Connect data and run the pilot before updating this board; it is not connected to live commercial data.
GEO, CVR, Uplift, ROI: what do these terms mean here?
- GEOGenerative Engine Optimization
- Improve the visibility of genuine, verifiable content in generated answers. Deliver evidence pages and query tests without guaranteed indexing or rank.
- CVRConversion Rate
- Conversion rate: net purchases by unique eligible visitors here, supported by reconciled visitor, payment and refund records.
- UpliftIncrementality
- Incremental effect: compare concurrent treatment and control groups and report percentage-point differences, sample sizes and uncertainty.
- ROIReturn on Investment
- Return: (incremental contribution margin − pilot investment) ÷ pilot investment × 100%. Investment includes service, maintenance and promotion, excludes order-variable costs already deducted, and uses the same period.
Terminology and measurement references: GEO · KDD 2024 · Google Analytics · Google AI Search
Google says existing SEO fundamentals apply to its AI search and indexing is not guaranteed. Net purchases and incremental margin here need actual orders and costs; generic analytics key events are insufficient.
Which evidence informs consumer choice and produces verifiable enquiries and paid conversion?
What does this project appraise?
Evidence requirements
Product identity, dose, registration or filing materials, human studies and safety.
Deliverables
Claim-to-evidence map, purchase FAQs and partner materials, agent discovery testing, controlled sales pilot and outcome report.
Product and communication scope
Review jurisdiction and product identity; overseas supplements do not automatically have domestic health-food status.
From inputs to usable outputs
01
Product and intended use
Supply model, formulation or programme components, jurisdiction, target population, claims and available inputs.
02
Claim-by-claim appraisal
Trace sources, appraise study quality, comparators, dose or version and use conditions, retaining contrary findings and uncertainty.
03
Readable and queryable outputs
Deliver report, evidence cards, claims and limitations, partner summary and structured data; turn gaps into a study plan.
04
Validate use
Evaluate agent answers and citations or run a channel pilot as scoped; track scientific findings and business outcomes separately.
How can agents and partners use the evidence?
Query and comparison
Compare evidence, use conditions and limits for a population and goal; scope professional contexts such as medicines by use and audience.
Partner prospecting
Screen retail, professional services, hospital procurement or enterprise buyers by intended use, with reviewable partner materials.
Value validation
Measure understanding, qualified enquiries, procurement appraisal efficiency and agreed metrics. Validate indexing, recommendation and sales separately.
Fees cover the work. Evidence determines the findings.
Quote by products, claims, literature workload and specialist review. Project fees cover evidence construction, annual fees cover maintenance; studies, integrations and channel development are scoped separately. This is a service description, not a completed client outcome.
View current findings from the Libaorui case
Dossier-review findings, claim opportunities, delivery milestones and a business scenario calculator.
Define your product and evidence question.
Provide product identity, customers, claims and inputs for a scoped quote.